Ex-Ripple CRO Acquires Controlling Stake in Know Labs, Deploys Bitcoin Treasury Strategy

Know Labs, Inc. (NYSE American: KNW), a leader in non-invasive health monitoring technologies, has entered into a landmark agreement with Goldeneye 1995 LLC, an investment affiliate of Greg Kidd, former Chief Risk Officer at Ripple.
The deal will give Kidd’s entity a controlling interest in the company, alongside a sweeping leadership transition that includes Kidd becoming Chief Executive Officer and Chairman of the Board.
1,000 BTC Infusion and Bitcoin-Focused Treasury Model
Under the agreement, Goldeneye 1995 LLC will acquire shares of Know Labs by contributing 1,000 Bitcoin and a cash sum to retire debt, redeem preferred equity, and inject new working capital. Shares will be purchased at $0.335 per share, with the Bitcoin forming the core of the company’s new treasury strategy.
“I’m thrilled to deploy a Bitcoin treasury strategy with the support of a forward-looking organization like Know Labs at a time when market and regulatory conditions are particularly favorable,” said Kidd.
The company will transition to using the multiple of net asset value (mNAV) model to gauge investor sentiment. Based on a $105,000 BTC price, Bitcoin will make up 82% of the company’s $128 million market cap, yielding an implied entry mNAV multiple of 1.22x.
Strategic Shift and Leadership Realignment
Know Labs’ founder, Ron Erickson, will assume the role of President of a new division dedicated to continuing the company’s diagnostic research, and will serve as Vice Chairman of the Board.
“Partnering with Greg Kidd marks a pivotal next chapter for Know Labs,” said Erickson. “Greg’s visionary leadership positions Know Labs for a bold future.”
Bringing Bitcoin Yield to Public Markets
Kidd’s team will also migrate their existing Bitcoin yield generation strategy to the public sphere, aiming to combine digital asset exposure with growth-oriented public market governance. The move signals a new hybrid model in corporate finance—merging traditional equities with Bitcoin-centric treasury infrastructure.
This marks one of the largest BTC-based acquisitions for a publicly traded health tech firm, and is expected to reshape Know Labs into a Bitcoin-forward innovator at the intersection of blockchain finance and healthcare.